Investigating the alterations of endocannabinoidome signaling in the human small intestine in the context of obesity and type 2 diabetes

Background: Human studies have linked obesity-related diseases, such as type-2 diabetes (T2D), to the modulation of endocannabinoid signaling. Cannabinoid CB1 and CB2 receptor activation by the endocannabinoids (eCBs) 2-arachidonoylglycerol (2-AG) and N-arachidonoylethanolamine (AEA), both derived f...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Volatiana Rakotoarivelo, Bénédicte Allam-Ndoul, Cyril Martin, Laurent Biertho, Vincenzo Di Marzo, Nicolas Flamand, Alain Veilleux
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2024-03-01
coleção:	Heliyon
Assuntos:	Obesity Insulin resistance Diabetes Endocannabinoids Monoacylglycerols (MAGs) N-Acyl-ethanolamines (NAEs)
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2405844024029992
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!